CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 4 Open-market buy COO bought 3,200 shares at $0.39 ($1,248)
- 10-K/A Report 10-K/A
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Executive or director change
- 4 Open-market buy Director & COO bought 5,000 shares at an average $0.39 ($1,925)
- 4 Open-market buy Chairman and CEO bought 7,000 shares at an average $0.49 ($3,450)
- 4 Open-market buy Chairman and CEO bought 23,351 shares at an average $0.41 ($9,573)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Director & COO bought 15,100 shares at an average $0.89 ($13,514)
- 8-K Event Results of operations
- 10-K Report Annual Report
Page 6 of 63 · 1,250 filings